|
|
Analysis on irrational application of traditional Chinese medicine injection for promoting blood circulation and removing blood stasis in clinical departments of orthopedic hospital |
CUI Hong-jiang, BAI Lu-lu, DUAN Qiu-xia, ZHOU Jin-wei |
Department of Pharmacy,the Second Affiliated Hospital of Inner Mongolia Medical University,Inner Mongolia Hohhot, 010010,China |
|
|
Abstract Objective To analyze the status of traditional Chinese medicine injection of blood circulation and blood stasis in clinical department of orthopedic hospital for the past three years,and to provide reference for promoting clinical rational drug use.Methods Retrospective survey was conducted in the clinical department of the hospital from January 2014 to December 2016,and the clinical data of the hospital were evaluated comprehensively by the number of varieties,sales amount,frequency of drug use and sorting ratio.Results From 2014 to 2016,the number of varieties and annual sales of traditional Chinese medicine injection of blood circulation and blood stasis were decreased year by year.The ranking of sales and the frequency of medication mainly focused on brain surgery,trauma and hand significant surgical;unreasonable number of drugs decreased from 4345 cases to 274 cases.Conclusion The medical institutions should actively adopt the new model of three-level quality control management to carry out gradual standardization of clinical irrational drug use.
|
Received: 15 June 2017
|
|
|
|
|
Cite this article: |
CUI Hong-jiang,BAI Lu-lu,DUAN Qiu-xia, et al. Analysis on irrational application of traditional Chinese medicine injection for promoting blood circulation and removing blood stasis in clinical departments of orthopedic hospital[J]. 中国当代医药, 2017, 24(25): 146-148.
|
|
|
|
URL: |
http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I25/146 |
[1] |
白晓菊.中药注射剂治疗心脑血管系统疾病用药分析[J].上海中医药杂志,2009,43(7):58-60.
|
[2] |
中华医学会骨科学分会.中国骨科大手术静脉血栓栓塞症预防指南[J].中华关节外科杂志(电子版),2009,3(3):380-383.
|
[3] |
沈国琴,黄贵平.我院骨科活血化瘀中药注射剂使用情况分析[J].中国药业,2014,23(16):66-68.
|
[4] |
任德权,张伯礼.中药注射剂临床应用指南[M].北京:人民卫生出版社,2011:149.
|
[5] |
陈新谦,金有豫,汤光.新编药物学[M].7版.北京:人民卫生出版社,2011:300.
|
[6] |
郭绍来,栾伟,徐艳萍.2005-2008年我院抗菌药物使用情况分析[J].中国医院用药评价与分析,2010,10(5):421-424.
|
[7] |
汪铁山,王莉,张莉婧,等.2007-2010年广州市某医院中药注射剂应用分析[J].中国医院用药评价与分析,2011,11(3):237-240.
|
[8] |
刘利军,肖龙华,等.超说明书用药认识问题及管理对策研究[J].中国医院用药评价与分析,2014,14(4):361-364.
|
[9] |
赵景菊,赵锦,刘保良,等.老年患者活血化瘀类中药注射剂不良反应及应对策略[J].临床合理用药杂志,2016,9(11):80-82.
|
[10] |
王颖,谭湘萍,司徒冰,等.我院超说明书用药的分级管理研究[J].中国药房,2017,28(10):1306-1310.
|
[11] |
管燕,王珊,刘红梅.我院住院患者注射用红花黄色素的使用情况[J].临床药物治疗杂志,2013,11(3):21-23.
|
[12] |
叶科.低分子肝素联合丹参多酚酸盐预防下肢骨折术后深静脉血栓形成临床效果观察[J].吉林医学,2015,36(6):1060-1062.
|
[13] |
梁家源,李硕,黎鉴秋,等.血栓通联合低分子肝素对老年髋部骨折患者术后深静脉血栓形成的预防效果研究[J].国际医药卫生导报,2014,20(24):3796-3798.
|
[14] |
潘祺琦,袁红宇.对超说明书用药的分类干预方案[J].药学与临床研究,2013,21(2):183-184.
|
[15] |
中华医学会儿科学分会临床药理学组.中国儿科超说明书用药专家共识[J].中华儿科杂志,2016,54(2):101-103.
|
|
|
|